Tardive dyskinesia in lobotomized patients
Leon-Andrade, C.; Volavka, J.; Anderson, B.; Yackulic, C.F.; Reker, D.
Biological Psychiatry 18(11): 1329-1332
1983
ISSN/ISBN: 0006-3223 PMID: 6140033 Document Number: 197274
Document emailed within 1 workday
Related Documents
Huh, L.; Lee, B.Ju. 2015: Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report Psychiatria Danubina 27(2): 195-197Camp, E.W. 1977: Tardive dyskinesia oral facial dyskinesia with moban Diseases of the Nervous System 38(9): 759
Yassa, R.; Ghadirian, A.M.; Schwartz, G. 1983: Prevalence of tardive dyskinesia in affective disorder patients Journal of Clinical Psychiatry 44(11): 410-412
Grimes, J.D. 1982: Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients Canadian Medical Association Journal 126(5): 468
Rittmannsberger, H.; Schöny, W. 1986: Prevalence of tardive dyskinesia in long-term hospitalized schizophrenic patients Der Nervenarzt 57(2): 116-118
Gualtieri, C.T.; Sprague, R.L. 1984: Preventing tardive dyskinesia and preventing tardive dyskinesia litigation Psychopharmacology Bulletin 20(3): 346-348
Bourgeois, M. 1977: Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital L'Encephale 3(4): 299-320
Gardos, G.; Cole, J.O.; Matthews, J.D.; Nierenberg, A.A.; Dugan, S.J. 1992: The acute effects of a loading dose of phenylalanine in unipolar depressed patients with and without tardive dyskinesia Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 6(4): 241-247
Karniol, I.G.; Portela, W. 1982: Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study Brazilian Journal of Medical and Biological Research 15(6): 389-394
Spivak, B.; Mester, R.; Abesgaus, J.; Wittenberg, N.; Adlersberg, S.; Gonen, N.; Weizman, A. 1997: Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients Journal of Clinical Psychiatry 58(7): 318-322
Nagao, T.; Ohshimo, T.; Mitsunobu, K.; Sato, M.; Otsuki, S. 1979: Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor Biological Psychiatry 14(3): 509-523
Chowdhury, K.L.; Jalali, R.K.; Abrol, A.; Saproo, R.K.; Shah, B.A.; Tramboo, R. 1991: Polypharmacy and tardive dyskinesia Journal of the Association of Physicians of India 39(6): 501-503
Gardos, G.; Sokol, M.; Cole, J.O.; Sniffin, C. 1976: Eye color and tardive dyskinesia Psychopharmacology Bulletin 12(2): 7 8-7 9
Gunne, L.M.; Häggström, J.E. 1985: Experimental tardive dyskinesia Journal of Clinical Psychiatry 46(4 Pt 2): 48-50
Calne, D.B.; Claveria, L.E.; Teychenne, P.F.; Haskayne, L.; Lodge-Patch, I.C. 1974: Pimozide in tardive dyskinesia Transactions of the American Neurological Association 99: 166-170
Wolf, M.E.; DeWolfe, A.S.; Ryan, J.J.; Lips, O.; Mosnaim, A.D. 1985: Vulnerability to tardive dyskinesia Journal of Clinical Psychiatry 46(9): 367-368
Granacher, R.P. 1978: The tardive dyskinesia syndrome Journal of the Kentucky Medical Association 76(1): 13-17
Mehta, D.; Eaton, J.; Burch, M.; Mehta, S. 1985: Observations in tardive dyskinesia Journal of Clinical Psychiatry 46(2): 73
Gunne, L.M.; Häggström, J.E.; Johansson, P.; Levin, E.D.; Terenius, L. 1988: Neurobiochemical changes in tardive dyskinesia L'Encephale 14(Special Issue): 167-173
Crane, G.E. 1971: More on amantadine in tardive dyskinesia New England Journal of Medicine 285(20): 1150-1151